Clinical Trial Update: AI-based Predictive and Interventional System for Early Detection of Non-compliance Risks With Oral Therapies in Lymphoma Patients.

View source ↗

Summary

A clinical trial evaluating an AI-based predictive and interventional system to detect non-compliance risks with oral therapies in Non-Hodgkin lymphoma patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Snippet

Sponsor: Grand Hôpital de Charleroi | Conditions: Lymphoma, Non-Hodgkin, Care Coordination | Status: RECRUITING